Abstract
Although abstinence from drug use is often a key goal of youth substance use treatment, transitioning to less harmful routes and types of drug use is desirable from both a clinical and public health perspective. Despite this, little is known about the trajectories of youth who inject drugs including changes in patterns of non-injection drug use. The At-Risk Youth Study (ARYS) is a longitudinal cohort of street-involved youth who use drugs in Vancouver, Canada. We used linear growth curve modeling to compare changes in non-injection drug use among participants who ceased injecting drugs for at least one 6-month period between September 2005 and May 2015 to matched controls who continued injecting over the same period. Of 387 eligible participants, 173 (44.7%) reported ceasing drug injection at least once. Non-injection drug use occurred during 160 (79.6%) periods of injection cessation. In adjusted linear growth curve analyses, the only non-injection drug use pattern observed to decrease significantly more than controls following injection cessation was daily crack/cocaine use (p = 0.024). With the exception of frequent crack/cocaine use, transitions out of injection drug use did not appear to coincide with increased reductions in patterns of non-injection drug use. Our findings indicate that most (80%) of the observed injection cessation events occurred in the context of ongoing substance use. Given that transitioning out of drug injection represents a significant reduction in risk and harm, efforts supporting vulnerable youth to move away from injecting may benefit from approaches that allow for ongoing non-injection drug use.
Similar content being viewed by others
References
Degenhardt L, Stockings E, Patton G, Hall WD, Lynskey M. The increasing global health priority of substance use in young people. Lancet Psychiatry. 2016;3(3):251–64. https://doi.org/10.1016/S2215-0366(15)00508-8.
Roy E, Haley N, Leclerc P, Sochanski B, Boudreau JF, Boivin JF. Mortality in a cohort of street youth in Montreal. JAMA. 2004;292(5):569–74. https://doi.org/10.1001/jama.292.5.569.
Boivin JF, Roy E, Haley N, du Fort GG. The healh of street youth: a Canadian perspective. Can J Public Health. 2005;96(6):432–7.
Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. N Engl J Med. 2016;375(3):229–39. https://doi.org/10.1056/NEJMoa1515195.
Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–93. https://doi.org/10.1097/00002030-200304110-00014.
Suryaprasad AG, White JZ, Xu FJ, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Inf Dis. 2014;59(10):1411–9. https://doi.org/10.1093/cid/ciu643.
Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D, et al. Incidence—a comparison between injection and noninjection drug users in New York City. J Urban Health. 2004;81(1):20–4. https://doi.org/10.1093/jurban/jth084.
Cooper HL, Brady JE, Ciccarone D, Tempalski B, Gostnell K, Friedman SR. Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin Infect Dis. 2007;45(9):1200–3. https://doi.org/10.1086/522176.
Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26(3):453–60. https://doi.org/10.1016/S0306-4603(00)00115-5.
Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39–45. https://doi.org/10.1016/j.drugalcdep.2006.07.009.
Roy E, Boudreau JF, Leclerc P, Boivin JF, Godin G. Trends in injection drug use behaviors over 10 years among street youth. Drug Alcohol Depend. 2007;89(2–3):170–5. https://doi.org/10.1016/j.drugalcdep.2006.12.025.
Kerr T, Marshall BD, Miller C, et al. Injection drug use among street-involved youth in a Canadian setting. BMC Public Health. 2009;9(1):171. https://doi.org/10.1186/1471-2458-9-171.
Debeck K, Kerr T, Marshall BD, Simo A, Montaner J, Wood E. Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2013;133(2):468–72. https://doi.org/10.1016/j.drugalcdep.2013.07.008.
Auerswald CL, Lin JS, Parriott A. Six-year mortality in a street-recruited cohort of homeless youth in San Francisco, California. PeerJ. 2016;4:e1909. https://doi.org/10.7717/peerj.1909.
Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012;175(4):302–8. https://doi.org/10.1093/aje/kwr318.
Roy E, Lemire N, Haley N, Boivin JF, Frappier JY, Claessens C. Injection drug use among street youth: a dynamic process. Can J Public Health. 1998;89(4):239–40.
Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health. 2006;38(4):462–4. https://doi.org/10.1016/j.jadohealth.2005.03.004.
Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. New injectors and the social context of injection initiation. Int J Drug Policy. 2009;20(4):317–23. https://doi.org/10.1016/j.drugpo.2008.06.003.
Roy E, Boivin JF, Leclerc P. Initiation to drug injection among street youth: a gender-based analysis. Drug Alcohol Depend. 2011;114(1):49–54. https://doi.org/10.1016/j.drugalcdep.2010.09.003.
Sherman SG, Fuller CM, Shah N, Ompad DV, Vlahov D, Strathdee SA. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J Psychoactive Drugs. 2005;37(4):437–43. https://doi.org/10.1080/02791072.2005.10399817.
Matson SC, Hobson G, Abdel-Rasoul M, Bonny AEA. Retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. J Addict Med. 2014;8(3):176–82. https://doi.org/10.1097/ADM.0000000000000035.
Stein BD, Kogan JN, Sorbero M. Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment. Drug Alcohol Depend. 2009;104(1–2):100–6. https://doi.org/10.1016/j.drugalcdep.2009.04.008.
Williams RJ, Chang SY. A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin Psychol Sci Prac. 2000;7(2):138–66. https://doi.org/10.1093/clipsy.7.2.138.
Winters KC, Botzet AM, Fahnhorst T. Advances in adolescent substance abuse treatment. Curr Psychiatry Rep. 2011;13(5):416–21. https://doi.org/10.1007/s11920-011-0214-2.
Merrall EL, Bird SM, Hutchinson SJ. A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996–2006. Addiction. 2013;108(2):377–84. https://doi.org/10.1111/j.1360-0443.2012.04066.x.
Ravndal E, Amundsen EJ. Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study. Drug Alcohol Depend. 2010;108(1–2):65–9. https://doi.org/10.1016/j.drugalcdep.2009.11.008.
Strang J, McCambridge J, Best D, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326(7396):959–60. https://doi.org/10.1136/bmj.326.7396.959.
Walley AY, Cheng DM, Quinn EK, Blokhina E, Gnatienko N, Chaisson CE, et al. Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs. Int J Drug Policy. 2017;39:114–20. https://doi.org/10.1016/j.drugpo.2016.10.022.
Hadland SE, Kerr T, Li K, Montaner JS, Wood E. Access to drug and alcohol treatment among a cohort of street-involved youth. Drug Alcohol Depend. 2009;101(1–2):1–7. https://doi.org/10.1016/j.drugalcdep.2008.10.012.
Lucas P, Reiman A, Earleywine M, et al. Cannabis as a substitute for alcohol and other drugs: a dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Res Theory. 2013;21(5):435–42.
Reiman A. Cannabis as a substitute for alcohol and other drugs. Harm Reduct J. 2009;6(1):35. https://doi.org/10.1186/1477-7517-6-35.
Draanen J, Corneau S, Henderson T, Quastel A, Griller R, Stergiopoulos V. Reducing service and substance use among frequent service users: a brief report from the Toronto Community Addictions Team. Subst Use Misuse. 2013;48(7):532–8. https://doi.org/10.3109/10826084.2013.787096.
Davis AK, Lauritsen KJ. Acceptability of non-abstinence goals among students enrolled in addiction studies programs across the United States. Subst Abus. 2016;37(1):204–8. https://doi.org/10.1080/08897077.2015.1015702.
Rosenberg H, Davis AK. Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians. J Subst Abus Treat. 2014;46(2):214–8. https://doi.org/10.1016/j.jsat.2013.07.005.
Steensma C, Boivin JF, Blais L, Roy E. Cessation of injecting drug use among street-based youth. J Urban Health. 2005;82(4):622–37. https://doi.org/10.1093/jurban/jti121.
Wood E, Stoltz J-A, Montaner JSG, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J. 2006;3(1):18. https://doi.org/10.1186/1477-7517-3-18.
Werb D, Kerr T, Li K, Montaner J, Wood E. Risks surrounding drug trade involvement among street-involved youth. Am J Drug Alcohol Abuse. 2008;34(6):810–20. https://doi.org/10.1080/00952990802491589.
National Institute on Alcohol Abuse and Alcoholism. Drinking Levels Defined. 2017; Available at: http://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed September 1, 2015.
Burant CJ. Latent growth curve models: tracking changes over time. Int J Aging Hum Dev. 2016;82(4):336–50. https://doi.org/10.1177/0091415016641692.
Vlahov D, Safaien M, Lai S, Strathdee SA, Johnson L, Sterling T, et al. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS. 2001;15(17):2311–6. https://doi.org/10.1097/00002030-200111230-00013.
DeBeck K, Kerr T, Li K, Milloy MJ, Montaner J, Wood E. Incarceration and drug use patterns among a cohort of injection drug users. Addiction. 2009;104(1):69–76. https://doi.org/10.1111/j.1360-0443.2008.02387.x.
Lake S, Milloy MJ, Dong H, Hayashi K, Wood E, Kerr T, et al. Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs. Drug Alcohol Depend. 2016;169:73–9. https://doi.org/10.1016/j.drugalcdep.2016.10.017.
Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009;101(3):152–7. https://doi.org/10.1016/j.drugalcdep.2008.12.007.
Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988–2000. Drug Alcohol Depend. 2006;83(2):147–56. https://doi.org/10.1016/j.drugalcdep.2005.11.007.
Gaetz S, O'Grady W, Buccieri K, Karabanow J, Marsolais A. Youth Homelessness in Canada: implications for Policy and Practice. Toronto, CA: Canadian Homeless Research. Network. 2013;
Lau N, Sales P, Averill S, Murphy F, Sato SO, Murphy SA. Safer alternative: Cannabis substitution as harm reduction. Drug Alcohol Rev. 2015;34(6):654–9. https://doi.org/10.1111/dar.12275.
Novak SP, Bluthenthal R, Wenger L, Chu D, Kral AH. Initiation of heroin and prescription opioid pain relievers by birth cohort. Am J Public Health. 2015;106(2):298–300. https://doi.org/10.2105/AJPH.2015.302972.
Al-Tayyib AA, Koester S, Riggs P. Prescription opioids prior to injection drug use: comparisons and public health implications. Addict Behav. 2017;65:224–8. https://doi.org/10.1016/j.addbeh.2016.08.016.
Acknowledgments
We extend our gratitude to the participants of the At-Risk Youth Study for their contribution to the research. We would also like to thank past and present study staff including Cody Callon, Sabina Dobrer, Deborah Graham, Peter Vann, Steve Kain, and Tricia Collingham for their administrative support.
Funding
This study was supported by the United States National Institutes of Health (U01DA038886). Stephanie Lake is supported through doctoral awards from the Canadian Institutes of Health Research (CIHR) and the Pierre Elliott Trudeau Foundation (2017). Dr. Kora DeBeck is supported by a Michael Smith Foundation for Health Research/St. Paul’s Hospital Foundation-Providence Health Care Career Scholar Award and a CIHR New Investigator Award. Dr. Evan Wood receives support through a Tier 1 Canada Research Chair in Inner City Medicine. Dr. Kerr is supported by a foundation grant from the Canadian Institutes of Health Research (20R74326). Dr. Milloy is supported in part by the United States National Institutes on Health (R01-DA0251525), a New Investigator award from CIHR and a Scholar Award from the Michael Smith Foundation for Health Research. His institution has received an unstructured gift to support his research from NG Biomed, Ltd., an applicant to the Canadian federal government for a license to produce medical cannabis. Funding sources had no role in the design of this study; collection, analysis, and interpretation of the data; writing of the report; or the decision to submit the paper for publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lake, S., Kerr, T., Nosova, E. et al. Patterns of Non-injection Drug Use Associated with Injection Cessation among Street-Involved Youth in Vancouver, Canada. J Urban Health 95, 267–277 (2018). https://doi.org/10.1007/s11524-017-0225-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11524-017-0225-3